The utilization of nanoparticles derived from algae has generated increasing attention owing to their environmentally sustainable characteristics and their capacity to interact harmoniously with biologically active metabolites. The present study utilized P. boergesenii for the purpose of synthesizing copper oxide nanoparticles (CuONPs), which were subsequently subjected to in vitro assessment against various bacterial pathogens and cancer cells A375. The biosynthesized CuONPs were subjected to various analytical techniques including FTIR, XRD, HRSEM, TEM, and Zeta sizer analyses in order to characterize their stability and assess their size distribution. The utilization of Fourier Transform Infrared (FTIR) analysis has provided confirmation that the algal metabolites serve to stabilize the CuONPs and function as capping agents. The X-ray diffraction (XRD) analysis revealed a distinct peak associated with the (103) plane, characterized by its sharpness and high intensity, indicating its crystalline properties. The size of the CuONPs in the tetragonal crystalline structure was measured to be 76 nm, and they exhibited a negative zeta potential. The biological assay demonstrated that the CuONPs exhibited significant antibacterial activity when tested against both Bacillus subtilis and Escherichia coli. The cytotoxic effects of CuONPs and cisplatin, when tested at a concentration of 100 µg/mL on the A375 malignant melanoma cell line, were approximately 70% and 95%, respectively. The CuONPs that were synthesized demonstrated significant potential in terms of their antibacterial properties and their ability to inhibit the growth of malignant melanoma cells.
Introduction: Evaluating the anticancer property of Padina boergesenii mediated bimetallic nanoparticles.Methods: The present study focuses on synthesizing Se-ZnO bimetallic nanoparticles from an aqueous algal extract of brown algae Padina boergesenii.Synthesized Se-ZnO NPs were characterized by UV, FTIR, SEM-EDS and HRTEM for confirmation along with the anticancer activity by MTT assay.Results: The UV gave an absorbance peak at 342 and 370 nm, and the FTIR showed functional groups involved in synthesizing Se-ZnO NPs. The TEM micrographs indicated the crystalline nature and confirmed the size of the Se-ZnO NPs to be at an average size of 26.14 nm. Anticancer efficacy against the MCF-7 breast and HepG2 (hepatoblastoma) cell lines were also demonstrated, attaining an IC50 value of 67.9 µg and 74.9 µg/ml respectively, which caused 50% cell death.Discussion: This work aims to highlight an effective method for delivering bioactive compounds extracted from brown algae and emphasize its future therapeutic prospects. The potential of Selenium-Zinc oxide nanoparticles is of great interest due to the biocompatibility and low toxicity aspects of selenium combined with the cost-effectiveness and sustainability of zinc metal. The presence of bioactive compounds contributed to the stability of the nanoparticles and acted as capping properties.
29 January 2025 in Frontiers in Cellular and Infection Microbiology
Harnessing the immunomodulatory potential of bacterial metabolites opens up exciting possibilities for treating various immune-related disorders. However, turning this potential into a reality presents significant challenges. This review investigates these challenges, focusing on discovery, production, characterization, stability, formulation, safety, and individual variability limitations. The limited bioavailability of many metabolites, as well as potential improvements along with the potential for off-target effects and the importance of precise targeting, are emphasized. Furthermore, the complex interactions between gut bacterial metabolites and the microbiome are investigated, highlighting the importance of personalized approaches. We conclude by discussing promising advances in metagenomics, metabolomics, synthetic biology, and targeted delivery systems, which hold out hope for overcoming these limitations and paving the way for the clinical translation of bacterial metabolites as effective immunomodulators.
26 January 2024 in Journal of Drug Delivery Science and Technology
Phytoremediation is a process which effectively uses plants as a tool to remove, detoxify or immobilize contaminants. It has been an eco-friendly and cost-effective technique to clean contaminated environments. The contaminants from various sources have caused an irreversible damage to all the biotic factors in the biosphere. Bioremediation has become an indispensable strategy in reclaiming or rehabilitating the environment that was damaged by the contaminants. The process of bioremediation has been extensively used for the past few decades to neutralize toxic contaminants, but the results have not been satisfactory due to the lack of cost-effectiveness, production of byproducts that are toxic and requirement of large landscape. Phytoremediation helps in treating chemical pollutants on two broad categories namely, emerging organic pollutants (EOPs) and emerging inorganic pollutants (EIOPs) under in situ conditions. The EOPs are produced from pharmaceutical, chemical and synthetic polymer industries, which have potential to pollute water and soil environments. Similarly, EIOPs are generated during mining operations, transportations and industries involved in urban development. Among the EIOPs, it has been noticed that there is pollution due to heavy metals, radioactive waste production and electronic waste in urban centers. Moreover, in recent times phytoremediation has been recognized as a feasible method to treat biological contaminants. Since remediation of soil and water is very important to preserve natural habitats and ecosystems, it is necessary to devise new strategies in using plants as a tool for remediation. In this review, we focus on recent advancements in phytoremediation strategies that could be utilized to mitigate the adverse effects of emerging contaminants without affecting the environment.